Old Web
English
Sign In
Acemap
>
authorDetail
>
Omkar Subhash Marathe
Omkar Subhash Marathe
Cancer research
Medicine
Cancer
skin reaction
Tyrosine kinase
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II two-arm study of tepotinib plus osimertinib in patients with EGFR-mutant NSCLC and acquired resistance to first-line osimertinib due to MET amplification: INSIGHT 2.
2021
Journal of Clinical Oncology
Viola W. Zhu
Christine M. Bestvina
Gilberto Lopes
John T. Hamm
Melissa Lynne Johnson
Philip E. Lammers
Xiuning Le
Omkar Subhash Marathe
Luis E. Raez
Suman Rao
Joshua K. Sabari
Ronald J. Scheff
Umit Tapan
Jonathan Thompson
N. Karachaliou
Barbara Ellers-Lenz
Sabine Brutlach
Egbert F. Smit
Yi-Long Wu
Show All
Source
Cite
Save
Citations (1)
A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients.
2021
Journal of Clinical Oncology
Mario E. Lacouture
Milan J. Anadkat
Omkar Subhash Marathe
Nicholas J. Vogelzang
Elaine Tat Lam
Benjamin H. Kaffenberger
Jennifer N. Choi
Mark L. Webb
Robert Claude Tyler
Juegang Ju
Hong Tang
Jie Luo
Anisha B. Patel
Show All
Source
Cite
Save
Citations (0)
1